Why 1% of Revenue Is Worth Fighting For

March 4, 2026
Reading Time:

Hospitals operate on razor-thin margins. For some health systems across the country, net margins hover below 5%—meaning every dollar of revenue carries significant weight. So when industry data suggests that a structured zero-balance review program can recover up to an additional 1% of net revenue, it’s worth pausing on what that number actually means. 

One percent doesn’t sound like much. But for hospitals running on incredibly thin margins of less than 5%, that 1% is akin to 20% extra margin or more—a meaningful improvement for any healthcare organization. 

The Revenue That’s Already Been Earned 

The frustrating truth about underpayments is that this isn’t speculative revenue. It’s money hospitals have already earned by delivering care—money that was simply never fully collected. 

In 2023 alone, hospitals absorbed $130 billion in underpayments from Medicare and Medicaid. Medicare reimbursed just 83 cents for every dollar hospitals spent on patient care, and according to the American Hospital Association, those shortfalls grew at an average of 14% annually between 2019 and 2023. Commercial payers compound the problem further, with the American Medical Association reporting a 19.3% claims-processing error rate among commercial health insurers. 

Beyond outright denials, a quieter problem festers in zero-balance accounts—claims that were paid at some level, the account was closed, and the shortfall was buried. Industry analyses suggest underpayments caused by payer contract complexity can account for up to 10% of claims, with providers losing anywhere from 1%–7% of net revenue annually depending on payer mix and contract oversight. Some estimates place underpayment losses within payer contracts as high as 11% of net patient revenue 

Why Most of It Goes Uncollected 

The challenge isn’t awareness—revenue cycle leaders know underpayments exist. The challenge is the scale and complexity. 

Health systems routinely manage hundreds of payer contracts, each containing dense legal language governing fee schedules, carve-outs, episodic rates, billing provisions, and payment caps. Common errors include misapplied fee schedules, missed alternate revenue code logic, and payments falling below contractual minimums. Every one of these can close as a zero-balance account without ever triggering a follow-up. 

For revenue cycle teams already stretched thin, zero-balance review has historically fallen to the bottom of the priority list. The math simply didn’t work: the cost of manually identifying and pursuing each underpayment often exceeded the expected recovery. So the accounts stayed closed, and the revenue stayed uncollected. 

That calculation is changing. 

What AI Makes Possible 

Artificial intelligence, along with human expertise, is fundamentally altering the economics of underpayment recovery. Where manual review could only ever capture a selective subset of zero-balance opportunities, AI contract modeling analyzes accounts at scale—comparing them against extracted contract terms and payment rules to identify entire classes of claims that were underpaid due to contract misinterpretation, payer system errors, or missed billing provisions. 

The result isn’t just faster analysis. It’s more complete analysis. The full spectrum of underpayment opportunities can now be surfaced, including lower-dollar claims that once migrated to zero-balance status because the returns didn’t justify a manual appeal effort. At scale, those smaller recoveries add up quickly. 

According to data from Aspirion’s nationwide client base, 79% of underpayment recoveries exceed $1,000, with the most common range falling between $1,001 and $2,500, accounting for 26% of all recoveries. Unknown and underworked denials represent the single largest category of recovery opportunity at 54%—revenue that is hiding in plain sight, waiting to be claimed. 

On the clinical side, AI-powered documentation analysis addresses the growing wave of clinical denials. Payers have shifted their scrutiny to the back end, deploying AI tools that review clinical documentation after care is delivered and questioning medical necessity on claims that were already paid.  

The Cost of Waiting 

For hospitals still relying on manual workflows, inaction has a price. More claims go unpursued. More accounts close and are forgotten. And the technology gap between providers and payers—which have been investing in AI-powered claims processing for years—continues to widen. 

The revenue cycle leaders who are moving now are already seeing faster appeal cycles, higher overturn rates, and meaningful reductions in cost-to-collect. According to McKinsey, AI enablement of the revenue cycle could cut cost-to-collect by 30%–60% while optimizing payment accuracy across the board. 

For health systems running on margins of less than 5%, the question isn’t whether 1% of net revenue is worth fighting for—it’s how much longer can the hospital afford not to capture it? 

Millions in earned revenue shouldn’t stay buried in closed accounts. Discover how Aspirion’s AI contract modeling and pricing engine—ContractIQ—backed by our US-based team of attorneys and clinicians, is helping healthcare organizations recover hidden revenue at unprecedented scale and speed. Turn contract complexity into revenue certainty. Connect with us today to learn more. 

Aspirion

Aspirion

Revenue cycle leaders don't need more on their plate—they need a partner who can handle what their teams can't. Aspirion deploys proprietary AI and a specialized team of attorneys, clinicians, and claims experts to overturn denials, recover underpayments, and maximize out-of-network and complex claim reimbursement—with no operational burden on your staff. Trusted by hospitals and health systems nationwide, Aspirion is purpose-built to get providers paid accurately, quickly, and transparently so your team can focus on what matters most.

Contact Us

Find out how Aspirion’s Revenue Cycle Management services will optimize reimbursement for your most challenging claims.